Literature DB >> 14592593

Defective embryogenesis with angiotensin II receptor antagonists in pregnancy.

R M Cox1, J M Anderson, P Cox.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 14592593

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


× No keyword cloud information.
  10 in total

Review 1.  Effects of maternally administered drugs on the fetal and neonatal kidney.

Authors:  Farid Boubred; Mariella Vendemmia; Patricia Garcia-Meric; Christophe Buffat; Veronique Millet; Umberto Simeoni
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

2.  Angiotensin-II receptor 1 antagonist fetopathy--risk assessment, critical time period and vena cava thrombosis as a possible new feature.

Authors:  Marc Oppermann; Stephanie Padberg; Angela Kayser; Corinna Weber-Schoendorfer; Christof Schaefer
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

3.  Roles of the Angiotensin System in Neonatal Lung Injury and Disease.

Authors:  Chintan Gandhi; Bruce D Uhal
Journal:  JSM Atheroscler       Date:  2016-11-02

4.  Postnatal acute renal failure after fetal exposure to angiotensin receptor blockers.

Authors:  Luca Marchetto; Desiree Sordino; Giuseppe De Bernardo; Daniele Trevisanuto
Journal:  BMJ Case Rep       Date:  2015-07-02

Review 5.  Outcomes of 83 fetuses exposed to angiotensin receptor blockers during the second or third trimesters: a literature review.

Authors:  Chisa Shimada; Rina Akaishi; Kazutoshi Cho; Mamoru Morikawa; Yosuke Kaneshi; Takahiro Yamda; Hisanori Minakami
Journal:  Hypertens Res       Date:  2015-02-19       Impact factor: 3.872

Review 6.  Efficacy and safety of angiotensin II receptor type 1 antagonists in children and adolescents.

Authors:  Siegtraut Dorothea Herder; Ernst Weber; Almuth Winkemann; Christoph Herder; Hartmut Morck
Journal:  Pediatr Nephrol       Date:  2010-05       Impact factor: 3.714

7.  Teratogenicity with angiotensin II receptor antagonists in pregnancy.

Authors:  E Boix; P Zapater; A Picó; O Moreno
Journal:  J Endocrinol Invest       Date:  2005-12       Impact factor: 4.256

8.  The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers.

Authors:  Myla E Moretti; Daniela Caprara; Irina Drehuta; Emily Yeung; Stefanie Cheung; Lisa Federico; Gideon Koren
Journal:  Obstet Gynecol Int       Date:  2011-12-13

9.  Prenatal hypocalvaria after prolonged intrauterine exposure to angiotensin II receptor antagonists.

Authors:  Marine Lallemant; Sarah Prévost; François Nobili; Didier Riethmuller; Rajeev Ramanah; Marie-France Seronde; Nicolas Mottet
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2018 Oct-Dec       Impact factor: 1.636

10.  Reversible Fetal Renal Impairment following Angiotensin Receptor Blocking Treatment during Third Trimester of Pregnancy: Case Report and Review of the Literature.

Authors:  Tal Saar; Lorinne Levitt; Hagai Amsalem
Journal:  Case Rep Obstet Gynecol       Date:  2016-09-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.